OCC 1.35% 37.5¢ orthocell limited

An insider, the founder of SurgCenter, essentially a vast day...

  1. 7,287 Posts.
    lightbulb Created with Sketch. 6533
    An insider, the founder of SurgCenter, essentially a vast day hospital network in the US, has just bought 10,000,000 shares in MSB.

    Now I apologise to those who hate MSB discussions to OCC, but there is relevance.

    Someone like SurgCenter could very easily be interested in OCC's applications. They are a company that has "performed over 4100 Total Joint Replacements, more than any other outpatient surgery center in the United States". As a massive outpatient and short term stay hospital network with orthopedic specialisation, if they are looking at MSB, they will not be unaware of OCC's ATI treatment, Remplir or CelGro's tendon application.

    MSB is a very riskier investment to me than OCC. OCC's treatment and products are far more easily encompassed in their existing treatment schedules. Its arguably a better fit.....both in investment and business terms.

    US big Pharma is starting to sniff around orthopedic technologies, as I and Veritas have pointed out recently.....
    Last edited by bedger: 03/05/23
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
37.5¢
Change
0.005(1.35%)
Mkt cap ! $78.49M
Open High Low Value Volume
36.5¢ 37.5¢ 36.5¢ $32.14K 86.68K

Buyers (Bids)

No. Vol. Price($)
1 65604 37.5¢
 

Sellers (Offers)

Price($) Vol. No.
38.0¢ 5000 1
View Market Depth
Last trade - 12.55pm 10/05/2024 (20 minute delay) ?
Last
37.5¢
  Change
0.005 ( 1.35 %)
Open High Low Volume
37.0¢ 38.0¢ 37.0¢ 21015
Last updated 12.55pm 10/05/2024 ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.